Latest Breaking News On - Emerald mutual fund advisers trust - Page 1 : comparemela.com

Quanterix (NASDAQ:QTRX) Reaches New 12-Month Low at $14 26

Quanterix (NASDAQ:QTRX) Reaches New 12-Month Low at $14 26
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesLauriej olsonAsia pacificLord abbettQuanterix corporationQuanterix company profileEmerald mutual fund advisersQuanterix coSecurities exchange commissionCanaccord genuity groupVanguard group incGotham asset managementGet free reportGenuity groupTrading downDirector laurie

TransMedics Group, Inc (NASDAQ:TMDX) CFO Stephen Gordon Sells 15,000 Shares

TransMedics Group, Inc (NASDAQ:TMDX) CFO Stephen Gordon Sells 15,000 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankPiper sandlerStephen gordonTransmedics groupYork mellon corpJpmorgan chase coMorgan stanleyEmerald mutual fund advisersQuarter for transmedics groupCanaccord genuity groupTransmedics group incTransmedics group trading downMirae asset global investments coNews ratings for transmedics group dailyGet free report

ACADIA Pharmaceuticals (ACAD) Market Perform Rating Reaffirmed at Oppenheimer

Oppenheimer restated their market perform rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report released on Monday, Benzinga reports. The brokerage currently has a $19.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on ACAD. Mizuho cut shares of ACADIA Pharmaceuticals from […]

United statesZurcher kantonalbank zurich cantonalbankJames kiharaStephen davisMirae asset global investments coMorgan stanleyPharmaceuticals stock downPharmaceuticals incPharmaceuticals company profileEmerald mutual fund advisersRaymond james associatesPharmaceuticals dailyEmerald advisersRoyal bankFree reportModerate buy

Axos Financial (NYSE:AX) Stock Rating Reaffirmed by Keefe, Bruyette & Woods

Axos Financial (NYSE:AX – Get Free Report)‘s stock had its “outperform” rating reissued by Keefe, Bruyette & Woods in a note issued to investors on Thursday, Benzinga reports. They presently have a $79.00 price target on the stock, up from their previous price target of $77.00. Keefe, Bruyette & Woods’ target price points to a […]

United statesPiper sandlerBruyette woodRaymond jamesZurcher kantonalbank zurich cantonalbankSara wardell smithAndrewj michelettiEmerald mutual fund advisersEmerald advisersSecurities exchange commissionMirae asset global investments coAxos financial company profileAxos financial incSg americas securitiesAxos financialGet free report

ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Overweight Rating from Cantor Fitzgerald

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $37.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 117.01% from […]

United statesBrendan teehanZurcher kantonalbank zurich cantonalbankStephen davisRaymond james associatesPharmaceuticals incNeedham companyPharmaceuticals stockEmerald mutual fund advisersCantor fitzgeraldAcadia pharmaceuticalsPharmaceuticals dailyEmerald advisersMirae asset global investments coSecurities exchange commissionGet free report